AP
AGN

Archon Partners’s Allergan plc AGN Stock Holding History

Archon Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,041
Closed -$7.59M – 65
2017
Q3 		$7.59M Buy
37,041
+7,000
+23% +$1.63M 1.77% 30
2017
Q2 		$7.3M Buy
30,041
+1,875
+7% +$441K 1.7% 32
2017
Q1 		$6.73M Hold
28,166
– – 1.58% 32
2016
Q4 		$5.92M Sell
28,166
-10,128
-26% -$2.1M 1.55% 32
2016
Q3 		$8.82M Buy
38,294
+5,060
+15% +$1.24M 2.34% 24
2016
Q2 		$7.68M Buy
33,234
+2,599
+8% +$599K 2.09% 28
2016
Q1 		$8.21M Buy
30,635
+571
+2% +$163K 2.26% 24
2015
Q4 		$9.39M Buy
30,064
+424
+1% +$126K 2.54% 16
2015
Q3 		$8.06M Hold
29,640
– – 2.38% 19
2015
Q2 		$8.99M Hold
29,640
– – 2.33% 16
2015
Q1 		$8.82M Buy
29,640
+714
+2% +$204K 2.22% 18
2014
Q4 		$7.45M Hold
28,926
– – 1.93% 27
2014
Q3 		$6.98M Buy
+28,926
New +$6.47M 1.92% 28

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Archon Partners's AGN Position: Q4 2017 in Review

Archon Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 37,041 shares — an estimated $7.59M sold.

Archon Partners first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $9.39M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Archon Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Archon Partners sold 37,041 Allergan plc shares in Q4 2017, an estimated $7.59M.
  • Archon Partners first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Archon Partners's Allergan plc position peaked at $9.39M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Archon Partners's 13F filing for Q4 2017, filed 5 Feb 2018.